Allison M J Anacker1, Jacqueline T Moran2,3, Sara Santarelli2, C Gunnar Forsberg4, Tiffany D Rogers4, Gregg D Stanwood5, Benjamin J Hall2,3, Eric Delpire4, Jeremy Veenstra-VanderWeele1,4, Michael D Saxe2. 1. Division of Child & Adolescent Psychiatry, New York State Psychiatric Institute, Columbia University, New York, New York. 2. Roche Pharmaceutical Research and Early Development, Neuroscience, Ophthalmology and Rare Diseases, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland. 3. Tulane University Department of Cell and Molecular Biology and the Neuroscience Program, New Orleans, Louisiana. 4. Departments of Psychiatry, Pediatrics, and Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee. 5. Department of Biomedical Sciences, Florida State University College of Medicine, Tallahassee, Florida.
Abstract
The K-Cl cotransporter KCC2 is essential in the development of the "GABA switch" that produces a change in neuronal responses to GABA signaling from excitatory to inhibitory early in brain development, and alterations in this progression have previously been hypothesized to play a causal role in autism spectrum disorder (ASD). We investigated the KCC2b (Slc12a5) heterozygous knockout mouse using a battery of rodent behavioral tests relevant to core and comorbid ASD symptoms. Compared to wild-type littermates, KCC2+/- mice were normal in standard measures of locomotor activity, grooming and digging behaviors, and social, vocalization, and anxiety-like behaviors. However, KCC2+/- mice exhibited increased social dominance behaviors and increased amplitude of spontaneous postsynaptic currents in the medial prefrontal cortex (PFC) that were previously implicated in governing social hierarchy and dominance behaviors. Treatment of wild-type mouse brain slices with the KCC2 inhibitor VU0240511 increased the amplitude and frequency of excitatory postsynaptic currents, partially recapitulating the phenotype of KCC2+/- mice. These findings indicate that the activity of KCC2 plays a role in social dominance, in parallel with effects on PFC signaling, further suggesting that KCC2 function has some relevance to social behavior but without the breadth of impact on autism-like behavior suggested by previous studies. Further testing could assess whether KCC2 alters other circuits and whether additional factors such as environmental insults may precipitate autism-related behavioral phenotypes. Autism Research 2019, 12: 732-743.
The K-Cl cotransporter KCC2 is essential in the development of the "GABA switch" that produces a change in neuronal responses to GABA signaling from excitatory to inhibitory early in brain development, and alterations in this progression have previously been hypothesized to play a causal role in autism spectrum disorder (ASD). We investigated the KCC2b (Slc12a5) heterozygous knockout mouse using a battery of rodent behavioral tests relevant to core and comorbid ASD symptoms. Compared to wild-type littermates, KCC2+/- mice were normal in standard measures of locomotor activity, grooming and digging behaviors, and social, vocalization, and anxiety-like behaviors. However, KCC2+/- mice exhibited increased social dominance behaviors and increased amplitude of spontaneous postsynaptic currents in the medial prefrontal cortex (PFC) that were previously implicated in governing social hierarchy and dominance behaviors. Treatment of wild-type mouse brain slices with the KCC2 inhibitor VU0240511 increased the amplitude and frequency of excitatory postsynaptic currents, partially recapitulating the phenotype of KCC2+/- mice. These findings indicate that the activity of KCC2 plays a role in social dominance, in parallel with effects on PFC signaling, further suggesting that KCC2 function has some relevance to social behavior but without the breadth of impact on autism-like behavior suggested by previous studies. Further testing could assess whether KCC2 alters other circuits and whether additional factors such as environmental insults may precipitate autism-related behavioral phenotypes. Autism Research 2019, 12: 732-743.
Authors: Janne Tornberg; Vootele Voikar; Harri Savilahti; Heikki Rauvala; Matti S Airaksinen Journal: Eur J Neurosci Date: 2005-03 Impact factor: 3.386
Authors: Nam-Sik Woo; Jianming Lu; Roger England; Robert McClellan; Samuel Dufour; David B Mount; Ariel Y Deutch; David M Lovinger; Eric Delpire Journal: Hippocampus Date: 2002 Impact factor: 3.899
Authors: Volodymyr I Dzhala; Delia M Talos; Dan A Sdrulla; Audrey C Brumback; Gregory C Mathews; Timothy A Benke; Eric Delpire; Frances E Jensen; Kevin J Staley Journal: Nat Med Date: 2005-10-09 Impact factor: 53.440
Authors: Susan M Greene; Yatzil R Sanchez; Nikhita Pathapati; Gianna N Davis; Georgianna G Gould Journal: Horm Behav Date: 2021-01-20 Impact factor: 3.492